Investigator Site 40 - US0010003 — Chapel Hill, North Carolina

Investigator Site 40 - US0010003 is a clinical research site located in Chapel Hill, North Carolina, United States 27514.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Investigator Site 40 - US0010003 has participated in 1 clinical trials.

Therapeutic areas: Generalized Myasthenia Gravis.

Sponsors: argenx.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigator Site 40 - US0010003?

Investigator Site 40 - US0010003 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigator Site 40 - US0010003 conducted?

Investigator Site 40 - US0010003 has 1 clinical trials on record. Their work covers Generalized Myasthenia Gravis.

Is Investigator Site 40 - US0010003 accredited by Crixeo Health?

Investigator Site 40 - US0010003 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigator Site 40 - US0010003?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.